These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 35384591)
1. Ependymoma: Evaluation and Management Updates. Rudà R; Bruno F; Pellerino A; Soffietti R Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591 [TBL] [Abstract][Full Text] [Related]
2. Ependymomas of the adult: molecular biology and treatment. Rudà R; Gilbert M; Soffietti R Curr Opin Neurol; 2008 Dec; 21(6):754-61. PubMed ID: 18989122 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M; Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291 [TBL] [Abstract][Full Text] [Related]
4. Supratentorial and Infratentorial Ependymoma. Myseros JS Adv Tech Stand Neurosurg; 2024; 53():93-118. PubMed ID: 39287805 [TBL] [Abstract][Full Text] [Related]
5. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options. Dorfer C; Tonn J; Rutka JT Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369 [TBL] [Abstract][Full Text] [Related]
6. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series. Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560 [TBL] [Abstract][Full Text] [Related]
7. Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment. Träger M; Schweizer L; Pérez E; Schmid S; Hain EG; Dittmayer C; Onken J; Fukuoka K; Ichimura K; Schüller U; Dührsen L; Müther M; Paulus W; Thomas C; Gutt-Will M; Schucht P; Maragkou T; Schittenhelm J; Eckert F; Niyazi M; Fleischmann DF; Dorostkar MM; Feyer P; May SA; Moskopp D; Badakhshi H; Radke C; Walter J; Ehret F; Capper D; Kaul D Neuro Oncol; 2023 Jul; 25(7):1286-1298. PubMed ID: 36734226 [TBL] [Abstract][Full Text] [Related]
8. EANO guidelines for the diagnosis and treatment of ependymal tumors. Rudà R; Reifenberger G; Frappaz D; Pfister SM; Laprie A; Santarius T; Roth P; Tonn JC; Soffietti R; Weller M; Moyal EC Neuro Oncol; 2018 Mar; 20(4):445-456. PubMed ID: 29194500 [TBL] [Abstract][Full Text] [Related]
9. Spinal cord ependymomas in children and adolescents. Benesch M; Frappaz D; Massimino M Childs Nerv Syst; 2012 Dec; 28(12):2017-28. PubMed ID: 22961356 [TBL] [Abstract][Full Text] [Related]
10. Intracranial ependymomas of childhood: current management strategies. Smyth MD; Horn BN; Russo C; Berger MS Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361 [TBL] [Abstract][Full Text] [Related]
11. Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic. Soni N; Ora M; Bathla G; Desai A; Gupta V; Agarwal A AJNR Am J Neuroradiol; 2024 Nov; 45(11):1624-1634. PubMed ID: 38844368 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of chromosome 1q gain in intracranial ependymomas. Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097 [TBL] [Abstract][Full Text] [Related]
14. Intracranial ependymoma: factors affecting outcome. Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379 [TBL] [Abstract][Full Text] [Related]
15. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of histopathological ependymoma variants. Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042 [TBL] [Abstract][Full Text] [Related]
17. Ependymomas in Children and Adults. Lampros M; Vlachos N; Alexiou GA Adv Exp Med Biol; 2023; 1405():99-116. PubMed ID: 37452936 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups. Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101 [TBL] [Abstract][Full Text] [Related]